| Autor: |
Manik, Gemilyan, Gagik, Hakobyan, Lucie, Benejat, Bujana, Allushi, Davit, Melik-Nubaryan, Harutyun, Mangoyan, Amandine, Laur, Emilie, Daguerre, Eduard, Grigoryan, Francis, Megraud |
| Rok vydání: |
2019 |
| Předmět: |
|
| Zdroj: |
Gut Pathogens |
| ISSN: |
1757-4749 |
| Popis: |
Background The prevalence of Helicobacter pylori infection was never assessed in Armenia, nor was the prevalence of H. pylori resistance against the main antibiotics concerned, despite the fact that these data are fundamental to establish evidence-based recommendations for management of this infection. We aimed to fill this gap by assessing prevalence of H. pylori among adult population in Armenia and resistance of H. pylori strains to clarithromycin and levofloxacin. Methods Helicobacter pylori seroprevalence was determined in 217 asymptomatic adult subjects submitted to a health checkup using an ELISA. Molecular methods were used to detect H. pylori in gastric biopsies from 91 adult dyspeptic patients [55 (60.4%) were positive] as well as the mutations associated with clarithromycin resistance by real-time PCR and with levofloxacin by sequencing the gyrA QRDR. Results Helicobacter pylori seropositivity was found to be 41.5% globally and increased with age from 13.6% (age 18–25 years) to 83.3% (age > 65 years). Only two cases were found with a A2142/43G mutation causing clarithromycin resistance, and 6 cases showed mutations associated with levofloxacin resistance. Conclusions Helicobacter pylori infection is estimated to be about 42% among adults in Armenia and the low clarithromycin resistance allows the use of the standard triple therapy as a first line therapy. Electronic supplementary material The online version of this article (10.1186/s13099-019-0310-0) contains supplementary material, which is available to authorized users. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink